Jane Street’s CASI Pharmaceuticals CASI Stock Holding History

Jane Street’s Portfolio CASI Stock Details CASI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-12,538	Closed	-$89.8K	–	9243
2023 Q4	$89.8K	Sell	12,538 -9,586	-43%	-$46.1K	﹤0.01%	8623
2023 Q3	$56.6K	Sell	22,124 -6,038	-21%	-$14.3K	﹤0.01%	8120
2023 Q2	$70.4K	Buy	+28,162	New	+$75.7K	﹤0.01%	8130
2022 Q2	–	Sell	-2,143	Closed	-$17K	–	9717
2022 Q1	$17K	Sell	2,143 -3,199	-60%	-$25.1K	﹤0.01%	9976
2021 Q4	$43K	Buy	+5,342	New	+$53.2K	﹤0.01%	9586
2021 Q3	–	Sell	-5,342	Closed	-$83K	–	9960
2021 Q2	$83K	Buy	+5,342	New	+$89.9K	﹤0.01%	9341
2020 Q3	–	Sell	-1,255	Closed	-$31K	–	7174
2020 Q2	$31K	Buy	+1,255	New	+$27.3K	﹤0.01%	6929
2019 Q3	–	Sell	-1,089	Closed	-$35K	–	5115
2019 Q2	$35K	Buy	+1,089	New	+$34.8K	﹤0.01%	4987

Other funds holding CASI

WSCM

Wellington Shields Capital Management New York $788M AUM 66.95% 1-Year Est. Return

WSC

Wellington Shields & Co New York $446M AUM 38.92% 1-Year Est. Return

HCM

Howland Capital Management Boston, Massachusetts $2.77B AUM 19.56% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

CFM

Catalyst Funds Management Sydney NSW, Australia $1.78B AUM 107.3% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Jane Street's CASI Position: Q1 2024 in Review

Jane Street sold out of CASI Pharmaceuticals (CASI) in Q1 2024, closing a stake of 12,538 shares — an estimated $89.8K sold.

Jane Street first reported a position in CASI in Q2 2019 and held it in 8 quarters. The position peaked at $89.8K in Q4 2023. 20 funds tracked by Wall St. Rank hold CASI as of Q1 2024.

Jane Street reported no remaining CASI Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
Jane Street sold 12,538 CASI Pharmaceuticals shares in Q1 2024, an estimated $89.8K.
Jane Street first reported a position in CASI Pharmaceuticals in Q2 2019 and held it in 8 quarters.
Jane Street's CASI Pharmaceuticals position peaked at $89.8K in Q4 2023.
20 funds tracked by Wall St. Rank held CASI Pharmaceuticals as of Q1 2024.

Based on Jane Street's 13F filing for Q1 2024, filed 16 May 2024.